Category: chemotherapy drugs for mesothelioma

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The National Comprehensive Cancer Network (NCCN) has changed its first-line treatment recommendation for unresectable pleural mesothelioma, believing it will extend patient survival significantly. The NCCN advisory panel recently added the monoclonal antibody bevacizumab to the long-standing chemotherapy combination of pemetrexed and cisplatin. Bevacizumab, also known by brand name Avastin, inhibits the formation of new blood…

The post New Mesothelioma Treatment Guidelines May Extend Survival appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.